AZD-4017

N/A

Report date: 2025/08/01 20:01:42
NME

Base Information

Drug NameAZD-4017
Drug Alias NameAZD-4017
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsCushing SyndromeObesityDiabetes Mellitus, Type 2 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of OxfordAstrazeneca PlcUniversity Of Birmingham +[4] 
Active IndicationsN/A
Inactive IndicationsCushing SyndromeObesityDiabetes Mellitus, Type 2 +[4] 

Other Information

ATC CodeN/A
Related LinksN/A